FDA :: Actions Program for Medical Devices – Enhancing Patient Safety
The U.S. Food and Drug Administration (FDA) today announced its action plan for strengthening the way it monitors the safety of medical devices after they reach the marketplace.
The U.S. Food and Drug Administration (FDA) today announced its action plan for strengthening the way it monitors the safety of medical devices after they reach the marketplace.
Multiple research projects across three cooperating universities are demonstrating progress that is enabling American producers, processors and consumers to maintain a safe food supply. The Food Safety Consortium summarized that work in its recently completed annual report for the 2005-06 fiscal year.
Even as a more stringent law against sexual harassment of working women is in the pipeline, a study here has exposed rampant increase in such cases in the health sector.
Health care professionals say a computerized emergency response system for public health laboratories developed in Nebraska is proving to be a valuable tool for other states and has the potential to impact public health systems worldwide.
Senior health officials of the Mainland, Hong Kong and Macau today (November 6) reaffirmed the importance of co-operation and information exchange in a tripartite meeting.
UCSD bioengineers report in the November issue of Nature Genetics rapid evolutionary changes in a bacterial genome, observed in near-real time over a few days. Scientists have previously published static “snapshots” of the genome sequences of more than 100 bacterial species, but this new report shows how these genomes are moving targets.
A growth factor known to be important for the survival of many types of cells stimulates rapid extension of corticospinal motor neurons — critical brain cells that connect the cerebral cortex with the spinal cord and that die in motor neuron diseases like amyotrophic lateral sclerosis (ALS or Lou Gehrig’s disease).
Breast cancer survivors might one day avoid the prospect of invasive breast reconstruction surgery, opting instead for an approach that would involve using stem cells derived from their own fat, suggest University of Pittsburgh researchers who are studying the potential these cells may have for regenerating new breast tissue.
A significant and largely untapped global market exists for more effective and affordable tests to diagnose tuberculosis in low and middle income countries, where most TB cases today occur.
Novartis (NYSE: NVS) announced today results of pivotal Phase III clinical trial data for its innovative cell culture-derived influenza vaccine demonstrating that it is highly capable of producing an immune response (“immunogenic”), one at least as strong as the traditional egg-derived influenza vaccine Aggripal? for each of the three influenza strains studied.